Table 1.
Baseline sample characteristics by intervention group
Intervention group | |||
---|---|---|---|
Characteristic | RFA (n=30) | Sham (n=30) | P value*,† |
Sex, n (%) | 0.07 | ||
Male | 16 (53.3) | 9 (30.0) | |
Female | 14 (46.7) | 21 (70.0) | |
Race/Ethnicity, n (%) | 0.19 | ||
Non-Hispanic white | 24 (80.0) | 26 (86.7) | |
Non-Hispanic black | 5 (16.7) | 1 (3.3) | |
Hispanic | 1 (3.3) | 1 (3.3) | |
Other/Not reported | 0 (0.0) | 2 (6.7) | |
Age (years) | 63.1±8.5 | 66.8±7.6 | 0.08 |
Body mass index | 34.9±6.0 | 30.4±5.7 | <0.001 |
Pain at rest (0–10) | 4.8±2.7 | 4.6±2.2 | 0.82 |
Pain with ambulation (0–10) | 6.0±2.4 | 5.8±1.8 | 0.70 |
PROMIS—Physical Function (0–100) | 37.8±6.1 | 36.5±4.9 | 0.36 |
Note: All values are n (%) or mean±SD. PROMIS—Physical Function values are T scores, with a mean of 50 and an SD of 10. Lower values on this measure indicate greater functional limitations.
P value compares RFA versus sham groups.
χ2 tests were used for categorical measures and between-subject t-tests were used for continuous measures.
PROMIS, Patient Reported Outcome Measurement Information System; RFA, radiofrequency ablation.